Insider Andrew Regan Buys $190K in Open Market, Increases Stake to 5.4%
CDT is trading near its 52-week low of $1.775 (7.0% above the low).
Summary
Andrew Regan, CEO of Corvus Capital Ltd., made a $190,000 open market purchase of CDT Equity Inc. shares, increasing his beneficial ownership to 5.4%.
Key Events · Ownership and Investor Activity · CDT
-
Insider Open Market Purchase
Corvus Capital Ltd., controlled by CEO Andrew Regan, purchased 100,000 shares in the open market for $190,000 on May 13, 2026.
-
Warrant Exercise
Corvus Capital Ltd. received 147,401 shares on March 24, 2026, through a cashless exercise of pre-funded warrants, after the 1-for-25 reverse stock split.
-
Increased Beneficial Ownership
Andrew Regan now beneficially owns 262,766 shares, representing 5.4% of the company's outstanding common stock.
Analysis · CDT · Life Sciences
This filing indicates a significant vote of confidence from Andrew Regan, CEO of Corvus Capital Ltd., who increased his beneficial ownership through a $190,000 open market purchase. This buying activity is particularly notable given the company's recent disclosures of a going concern warning and substantial share dilution events, suggesting strong conviction in the company's future despite financial challenges.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.7% of the 583 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDT was trading at $1.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $1.78 to $1,229.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.